• ALFApump

alfapump® receives CE Approval

Sequana Medical is pleased to announce that it has now also received CE mark approval for use of its alfapump system in patients with ascites caused by cancer (malignant ascites). The alfapump system was first introduced to the European market last year for patients with refractory ascites caused by advanced liver disease. We also want to express our gratitude to Temir Bank,  which provided us with the necessary investments. Detail information about company you can get here: https://temirbank.kz